Despite activation of the PI3K-AKT-mTOR pathway being a common feature of many cancers, and activation of this pathway being associated with regulation of a number of metabolic effects, comprehensive profiling of the consequence of PIK3CA mutations on metabolic dependencies has not been studied. This evidence concerns the gene MTOR and cancer.